Exciting topics, interestingly presented: Every first and third Thursday (except during school holidays), RESIST scientists or top-class researchers from external institutions present their topics at the RESIST seminar series.
Attend these exciting seminars of the Cluster of Excellence RESIST, as a member of RESIST or as a colleague or student.
On 23 April 2026 at 1:00 p.m., Prof. Dr. Britta Eiz-Vesper, Institute of Transfusion Medicine and Transplant Engineering (ITT), will give a lecture on “Personalized adoptive T-cell therapy to treat viral complication”.
Britta Eiz-Vesper’s research advances allogeneic antiviral T-cell therapy and next-generation CAR/TCR engineering for the treatment of viral infections, virus-induced malignancies, solid tumors, and transplant rejection. She co-founded the world’s first T-cell donor registry (alloCELL.org) and has been instrumental in establishing immune monitoring and quality standards for antiviral T-cell therapies. Her work focuses on identifying suitable T-cell donors, delivering personalized antiviral immunotherapies to patients in need, and developing monitoring programs for pathogen-specific T cells in immunocompromised individuals with or without transplants. To date, more than 800 mono- and multivirus-specific T-cell products have been manufactured for patients at Hannover Medical School (MHH), in Germany, and across Europe. Her current research aims to elucidate the mechanisms that govern the function of adoptively transferred T cells and to further optimize T-cell–based immunotherapies.
The lecture will take place in Lecture Hall S, Building J01 of the Hannover Medical School.
If you are interested in participating online, please contact RESIST@mh-hannover.de.
Do you have any questions or suggestions about the RESIST seminar series? Then please contact us.